Data for ST001515   

(Analysis AN002512): Average values per metabolite and experimental factor (Units:scaled units)

Metabolite structureAll dataF1F2F3F4F5F6F7F8F9F10F11F12F13F14F15F16F17F18
1-oleoyl-GPS (18:1)
1.04 0.94 0.96 0.96 0.94 0.99 0.97 1.02 0.95 1.01 0.92 1.06 1.16 0.93 1.11 0.99 1.01 1.05
1-stearoyl-2-oleoyl-GPS (18:0/18:1)
1.27 1.28 1.26 1.62 0.95 1.16 0.72 0.91 0.96 0.92 0.70 0.87 0.91 0.87 1.21 0.82 0.84 0.89
3-decenoylcarnitine
1.37 0.90 0.81 0.60 0.97 1.00 1.08 0.79 0.81 0.71 0.99 0.93 1.53 1.25 1.24 1.23 1.27 1.16
3-hydroxydecanoylcarnitine
1.54 1.00 1.05 0.65 1.30 1.01 1.31 0.83 0.93 0.63 1.23 1.00 1.69 1.22 1.21 1.63 1.35 1.14
3-hydroxyoleoylcarnitine
1.10 1.21 1.22 0.42 1.24 0.81 1.16 1.03 1.39 0.67 1.38 1.05 1.31 0.70 0.84 1.80 1.14 0.99
4-cholesten-3-one
0.65 0.76 0.64 1.01 0.79 0.82 0.75 0.74 1.05 0.90 0.80 0.92 0.57 1.03 0.89 1.15 0.81 0.90
4-methylnonanoylcarnitine
1.28 0.54 0.58 0.93 0.57 0.71 1.00 0.53 0.63 0.83 0.46 0.81 1.07 0.88 1.00 1.03 0.99 0.99
5-dodecenoylcarnitine (C12:1)
1.50 0.84 0.89 0.64 1.08 1.03 1.43 0.84 1.08 0.77 1.28 1.02 1.49 0.95 1.10 1.58 1.22 1.04
adrenoylcarnitine (C22:4)*
1.16 0.86 0.89 0.74 1.02 1.17 1.13 0.80 0.93 0.75 0.85 0.95 1.15 0.88 0.90 1.06 1.11 0.93
alpha-tocopherol
1.03 0.97 1.08 1.00 1.03 1.00 0.85 0.93 1.02 0.88 0.98 0.94 1.14 1.14 1.12 1.02 1.12 1.01
arachidonoylcarnitine (C20:4)
1.22 1.05 0.98 0.93 1.05 1.07 1.12 0.82 0.92 0.82 0.92 0.97 1.20 0.98 0.99 1.24 1.22 0.98
arachidonoylcholine
0.98 0.97 0.84 1.50 0.79 0.84 1.00 1.29 1.15 1.47 0.87 1.02 1.30 1.52 1.79 1.56 1.46 1.66
arachidoylcarnitine (C20)*
1.04 0.93 1.03 1.00 1.00 0.87 0.96 0.89 0.89 0.96 0.83 1.03 1.08 1.04 1.06 1.03 1.25 1.16
behenoylcarnitine (C22)*
1.07 1.26 1.08 1.17 1.01 1.02 0.83 0.90 0.83 0.86 0.83 0.84 1.14 1.01 1.19 0.93 1.40 0.87
beta-cryptoxanthin
1.36 1.17 1.43 1.32 1.41 1.29 0.99 1.09 1.24 1.07 1.14 1.04 1.00 0.94 0.99 0.89 0.99 0.98
beta-sitosterol
1.13 1.26 1.58 1.11 1.40 1.07 0.90 0.98 1.08 0.91 0.94 0.97 1.05 1.26 1.02 0.94 1.15 1.10
bilirubin (E,Z or Z,E)*
1.12 0.75 0.85 1.01 0.89 1.02 1.04 1.02 1.24 1.18 1.13 0.94 1.16 0.96 1.01 1.14 0.92 0.88
biliverdin
1.28 0.53 0.78 0.81 0.78 0.96 2.46 0.93 1.13 1.62 1.42 1.78 1.28 0.78 0.97 1.63 1.50 1.20
campesterol
1.16 1.11 1.33 1.02 1.22 1.05 0.84 0.79 0.98 0.85 0.91 0.91 1.04 1.27 1.00 0.84 1.25 0.97
carotene diol (1)
1.34 1.12 1.25 1.28 1.26 1.27 0.99 0.93 0.95 0.98 0.96 1.03 1.11 1.10 1.01 0.95 1.04 0.99
carotene diol (2)
1.39 1.29 1.27 1.32 1.30 1.31 1.01 0.99 0.90 0.94 1.00 1.03 1.10 0.99 1.04 1.04 0.99 0.97
carotene diol (3)
1.36 1.16 1.36 1.29 1.30 1.35 1.06 1.01 0.94 1.03 1.08 1.18 1.08 1.03 0.95 0.98 1.02 0.96
cerotoylcarnitine (C26)*
1.18 1.09 1.14 1.16 1.05 1.16 0.91 0.86 0.84 0.93 0.80 0.90 1.17 1.09 1.07 1.11 1.08 1.12
cetirizine
0.53 0.53 0.53 0.53 0.53 0.53 0.99 0.56 0.55 1.03 0.53 0.59 0.53 0.53 0.53 0.53 0.53 0.53
cholesterol
1.05 0.88 0.98 1.00 0.95 0.98 0.97 0.86 0.91 0.96 0.89 0.98 1.15 1.07 1.03 1.05 1.09 1.04
cis-4-decenoylcarnitine (C10:1)
1.33 0.85 0.73 0.62 0.93 0.95 1.56 0.91 0.91 0.84 1.16 1.00 1.44 1.46 1.17 1.46 1.36 1.07
decanoylcarnitine (C10)
1.77 0.76 0.70 0.59 1.09 1.11 1.83 0.73 0.94 0.74 1.24 1.08 1.84 1.07 1.31 1.58 1.34 1.21
delta-tocopherol
0.97 1.67 0.76 0.72 1.06 0.95 1.12 1.74 0.80 0.67 1.06 1.35 0.91 1.87 0.88 0.58 0.77 0.93
dihomo-linolenoylcarnitine (C20:3n3 or 6)*
1.30 1.03 1.02 0.87 1.00 1.25 1.21 0.89 1.02 0.94 0.99 1.11 1.15 0.94 0.95 1.17 1.05 0.97
dihomo-linolenoyl-choline
1.23 1.01 0.64 1.66 0.54 1.01 1.13 1.28 0.97 1.68 0.66 1.23 1.04 1.19 1.38 1.45 0.99 1.38
dihomo-linoleoylcarnitine (C20:2)*
1.13 1.11 1.11 0.66 1.23 1.09 1.13 0.97 1.02 0.84 1.01 1.02 1.11 0.96 0.94 1.31 1.12 1.02
docosahexaenoylcarnitine (C22:6)*
1.28 1.18 0.80 0.87 0.93 1.04 0.76 0.91 0.68 0.58 0.68 0.59 1.13 1.05 1.10 1.41 1.27 0.91
docosahexaenoylcholine
0.98 0.97 0.98 1.50 0.84 0.74 0.81 1.08 0.97 1.21 0.64 0.81 1.29 1.38 1.51 1.43 1.33 1.52
eicosenoylcarnitine (C20:1)*
1.04 1.04 1.21 0.66 1.19 0.89 1.08 0.89 1.06 0.86 1.01 0.97 1.21 0.89 1.00 1.35 1.19 1.06
gamma-tocopherol/beta-tocopherol
1.08 1.12 0.83 0.90 0.98 1.08 0.93 1.11 0.79 0.81 0.97 1.05 1.32 1.71 1.15 1.13 1.17 1.27
heme
2.06 1.10 0.99 1.00 1.06 1.26 17.03 0.99 0.92 11.71 2.50 4.77 1.53 1.42 1.23 12.80 3.08 3.46
laurylcarnitine (C12)
1.54 0.91 0.85 0.70 1.14 1.07 1.50 0.81 1.09 0.76 1.28 1.04 1.56 0.95 1.08 1.55 1.19 1.06
lignoceroylcarnitine (C24)*
1.15 1.11 1.04 1.16 0.95 1.10 0.92 0.83 0.78 0.92 0.79 0.92 1.16 1.11 1.07 1.09 1.19 1.18
linolenoylcarnitine (C18:3)*
1.15 1.33 0.96 0.56 0.95 1.01 1.13 1.16 1.06 0.69 1.08 0.99 1.21 1.20 1.03 1.08 1.08 0.91
linoleoylcarnitine (C18:2)*
1.08 1.25 1.02 0.67 1.14 0.99 1.07 1.03 1.00 0.82 1.03 0.98 1.14 1.11 0.94 1.21 1.11 0.99
linoleoylcholine*
0.94 1.07 0.89 1.26 0.78 0.80 0.76 1.12 1.00 1.04 0.69 0.87 1.00 1.38 1.41 1.13 1.17 1.28
margaroylcarnitine (C17)*
1.05 0.82 1.07 0.65 1.05 0.97 1.18 0.77 1.09 0.88 1.04 1.07 1.16 0.70 0.96 1.18 1.05 1.04
myristoleoylcarnitine (C14:1)*
1.50 1.38 1.03 0.58 1.50 1.05 1.39 0.94 1.25 0.70 1.44 0.94 1.39 0.80 0.94 1.65 1.13 0.89
myristoylcarnitine (C14)
1.26 1.00 1.10 0.74 1.11 1.12 1.24 0.91 1.13 0.91 1.13 1.06 1.27 0.78 0.98 1.41 0.99 1.14
nervonoylcarnitine (C24:1)*
1.28 0.96 0.95 1.06 0.87 1.16 0.94 0.70 0.73 0.86 0.65 0.76 1.27 0.92 1.08 1.33 1.13 1.15
nonanoylcarnitine (C9)
1.40 0.67 0.76 0.69 0.79 1.02 1.63 0.77 1.01 0.83 1.12 1.10 1.49 1.08 1.22 1.35 1.29 1.12
octadecanedioylcarnitine (C18-DC)*
1.01 1.19 1.13 1.07 1.00 0.78 1.14 1.28 1.31 1.22 1.15 0.94 1.03 1.00 0.93 1.03 0.95 0.86
octadecenedioylcarnitine (C18:1-DC)*
0.97 1.56 1.17 0.85 0.99 0.77 1.06 1.38 1.29 1.06 1.20 1.02 1.03 1.05 0.94 1.33 1.03 0.89
octanoylcarnitine (C8)
1.56 0.75 0.75 0.56 0.95 1.10 1.82 0.76 1.02 0.81 1.26 1.15 1.73 1.19 1.23 1.55 1.41 1.20
oleoylcarnitine (C18)
1.15 1.01 1.12 0.62 1.18 0.98 1.14 0.88 1.10 0.82 1.13 1.02 1.16 0.80 0.93 1.30 1.05 0.97
oleoylcholine
1.08 1.04 0.83 1.42 0.68 0.80 0.88 1.09 0.98 1.23 0.69 0.89 1.11 1.25 1.49 1.32 1.19 1.42
palmitoleoylcarnitine (C16:1)*
1.28 1.02 1.07 0.58 1.25 1.02 1.32 0.90 1.27 0.84 1.30 1.13 1.30 0.79 0.95 1.57 1.11 1.02
palmitoylcarnitine (C16)
1.16 0.93 1.10 0.74 1.08 1.07 1.16 0.87 1.08 0.93 1.02 1.12 1.13 0.81 0.96 1.21 1.00 1.06
palmitoylcholine
0.98 0.99 0.81 1.35 0.73 0.81 0.82 1.19 1.04 1.24 0.75 0.96 1.13 1.36 1.46 1.28 1.18 1.40
palmitoyl-sphingosine-phosphoethanolamine (d18:1/16:0)
1.06 0.86 0.89 0.99 0.96 0.99 1.00 0.93 0.91 1.03 1.01 1.01 1.04 1.07 1.07 1.04 1.02 1.05
piperine
1.04 1.32 0.64 1.27 0.82 1.87 1.22 1.35 0.63 1.36 0.78 2.19 2.88 2.90 1.85 2.16 2.18 4.22
retinal
1.13 0.99 0.97 1.00 0.83 0.92 1.29 0.98 0.92 1.00 1.11 1.00 1.25 1.27 1.26 1.18 1.15 1.18
retinol (Vitamin A)
1.02 0.88 0.92 1.05 0.85 1.00 0.99 0.95 0.99 1.06 0.91 1.01 1.18 1.19 1.14 1.07 1.13 1.11
solanidine
1.88 1.55 1.14 1.60 1.32 1.29 0.77 0.77 0.87 0.82 0.50 0.56 0.55 0.68 0.61 0.41 0.48 0.51
sphingadienine
1.00 0.84 0.97 1.43 0.80 1.16 1.08 1.04 0.97 1.23 0.74 0.97 1.14 0.90 0.92 0.73 0.71 1.03
sphinganine
1.25 1.12 1.16 1.26 0.98 1.20 1.22 1.06 1.15 1.15 0.88 1.18 1.24 1.04 1.19 1.01 0.92 1.19
sphingosine
1.29 1.12 1.20 1.28 0.98 1.26 1.29 1.10 1.05 1.21 0.81 1.17 1.26 0.94 1.13 0.95 0.86 1.20
stearoylcarnitine (C18)
1.08 0.94 1.17 0.85 1.21 1.02 1.14 0.83 1.06 0.99 0.99 1.03 1.06 0.74 0.89 1.11 1.03 1.00
stearoylcholine*
0.98 0.98 0.79 1.43 0.71 0.77 0.83 1.15 0.96 1.26 0.69 0.93 1.06 1.35 1.53 1.27 1.22 1.38
undecenoylcarnitine (C11:1)
1.27 0.64 0.48 1.04 0.71 1.00 1.06 0.62 0.63 1.13 0.71 0.96 1.35 0.92 1.11 1.27 1.13 1.21
ximenoylcarnitine (C26:1)*
1.21 1.08 1.08 1.21 0.99 1.14 0.92 0.83 0.81 0.98 0.76 0.88 1.13 1.09 1.04 1.11 1.10 1.03

Factors:

F1Group:High-Dose | TIMEPOINT:-0.5HR
F2Group:High-Dose | TIMEPOINT:+23HR POST INFUSION
F3Group:High-Dose | TIMEPOINT:+47HR POST INFUSION
F4Group:High-Dose | TIMEPOINT:+4HR POST INFUSION
F5Group:High-Dose | TIMEPOINT:+71HR POST INFUSION
F6Group:High-Dose | TIMEPOINT:BASELINE
F7Group:Low-Dose | TIMEPOINT:-0.5HR
F8Group:Low-Dose | TIMEPOINT:+23HR POST INFUSION
F9Group:Low-Dose | TIMEPOINT:+47HR POST INFUSION
F10Group:Low-Dose | TIMEPOINT:+4HR POST INFUSION
F11Group:Low-Dose | TIMEPOINT:+71HR POST INFUSION
F12Group:Low-Dose | TIMEPOINT:BASELINE
F13Group:Placebo | TIMEPOINT:-0.5HR
F14Group:Placebo | TIMEPOINT:+23HR POST INFUSION
F15Group:Placebo | TIMEPOINT:+47HR POST INFUSION
F16Group:Placebo | TIMEPOINT:+4HR POST INFUSION
F17Group:Placebo | TIMEPOINT:+71HR POST INFUSION
F18Group:Placebo | TIMEPOINT:BASELINE
  logo